Literature DB >> 14216443

TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS.

T NAGATSU, M LEVITT, S UDENFRIEND.   

Abstract

Entities:  

Keywords:  ADRENAL GLANDS; ADRENAL MEDULLA; BRAIN ENZYMOLOGY; DOPA; DOPAMINE; EXPERIMENTAL LAB STUDY; FOLIC ACID; HISTOCYTOCHEMISTRY; HYDROXYLASES; LIVER CYTOLOGY; METABOLISM; MYOCARDIUM; NOREPINEPHRINE; SPLEEN; TRYPTOPHAN; TYROSINE; TYROSINE DECARBOXYLASE

Mesh：

Substances：

Year:  1964        PMID： 14216443

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  325 in total

1.  Modest neuropsychological deficits caused by reduced noradrenaline metabolism in mice heterozygous for a mutated tyrosine hydroxylase gene.

Authors:  K Kobayashi; Y Noda; N Matsushita; K Nishii; H Sawada; T Nagatsu; D Nakahara; R Fukabori; Y Yasoshima; T Yamamoto; M Miura; M Kano; T Mamiya; Y Miyamoto; T Nabeshima
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

Review 2.  Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma.

Authors:  G Eisenhofer; T T Huynh; M Hiroi; K Pacak
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

3.  A splice mutation in the GTP cyclohydrolase I gene causes dopa-responsive dystonia by exon skipping.

Authors:  M Skrygan; B Bartholomé; L Bonafé; N Blau; K Bartholomé
Journal:  J Inherit Metab Dis       Date:  2001-06       Impact factor: 4.982

4.  Correlation between serum dopamine-beta-hydroxylase activity and dopamine-beta-hydroxylase and tyrosine hydroxylase activities in central and peripheral adrenergic neurons and adrenal glands.

Authors:  T Nagatsu; T Kato; Y Numata; K Ikuta; M Sano; I Nagatsu; T Takeuchi; M Matsuzaki; H Umezawa
Journal:  Experientia       Date:  1977-05-15

5.  Increased catecholamine excretion in the rat after administration of alpha-methyl-tyrosine.

Authors:  M Beauvallet; J Roffi; Y Giudicelli; M Legrand-Tissot
Journal:  Experientia       Date:  1975-06-15

6.  Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite.

Authors:  Lydia M Mexas; Virginia R Florang; Jonathan A Doorn
Journal:  Neurotoxicology       Date:  2011-04-14       Impact factor: 4.294

7.  Alterations in the reduced pteridine contents in the cerebrospinal fluids of LRRK2 mutation carriers and patients with Parkinson's disease.

Authors:  Hiroshi Ichinose; Ken-Ichi Inoue; Shinobu Arakawa; Yuki Watanabe; Hiroki Kurosaki; Shoko Koshiba; Eldbjorg Hustad; Masahiko Takada; Jan O Aasly
Journal:  J Neural Transm (Vienna)       Date:  2017-09-01       Impact factor: 3.575

8.  Characterization of five evolutionary conserved regions of the human tyrosine hydroxylase (TH) promoter: implications for the engineering of a human TH minimal promoter assembled in a self-inactivating lentiviral vector system.

Authors:  Gaetano Romano; Sokreine Suon; Hao Jin; Angela E Donaldson; Lorraine Iacovitti
Journal:  J Cell Physiol       Date:  2005-08       Impact factor: 6.384

Review 9.  Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.

Authors:  Lan Guo; Jing Tian; Heng Du
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

10.  A dual role for the cAMP-dependent protein kinase in tyrosine hydroxylase gene expression.

Authors:  K S Kim; D H Park; T C Wessel; B Song; J A Wagner; T H Joh
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.